IL15 and systemic lupus erythematosus: The IFN-γ/IL-4 ratio of α-GalCer treated iNKT cells of controls but not SLE patients, could be enhanced by IL-15, (1.4±0.2% vs. 1.2±0.2%, p = 0.033).